Role of the impairment of oxidative metabolism in pathogenesis of lower urinary tract symptoms with benign prostatic hyperplasia and their treatment by α1-adrenoblocker alfuzosin
2002 ◽
Vol 19
(6)
◽
pp. 426-435
◽
2004 ◽
Vol 94
(3)
◽
pp. 338-344
◽
2007 ◽
Vol 99
(1)
◽
pp. 85-96
◽
2013 ◽
Vol 39
(4)
◽
pp. 264-269